TSVT - 2seventy bio, Inc.
4.99
-0.010 -0.200%
Share volume: 347,591
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$5.00
-0.01
0.00%
Summary score
41%
Profitability
35%
Dept financing
17%
Liquidity
58%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-18.03%
Return on assets
-6.86%
Return on sales
-391.38%
Return on invested capital
-20.26%
Total debt ratio
52.89%
Debt ratio change over timeo
-3.88%
Current Ratio
4.36%
Quick Ratio
4.17%
Cash Position Ratio
3.17%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-3.32%
Return on sales
-369.34%
Return on invested capital
0%
Total debt ratio
55.37%
Debt ratio change over timeo
-3.47%
Current Ratio
4.74%
Quick Ratio
0%
Cash Position Ratio
2.13%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-0.38%
Return on sales
-10.99%
Return on invested capital
0%
Total debt ratio
55.43%
Debt ratio change over time
0%
Current Ratio
4.8%
Quick Ratio
0%
Cash Position Ratio
2.23%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-2.43%
Return on assets
-56.65%
Return on sales
1633.19%
Return on invested capital
10.09%
Total debt ratio
-388.09%
Debt ratio change over time
-3.88%
Current Ratio
-25.62%
Quick Ratio
-26%
Cash Position Ratio
-21.86%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TSVT | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -18.03% | 14.28% | 9.23% | 0% |
| Return on assets | -6.86% | 4.23% | 3.2% | 0% |
| Return on sales | -391.38% | 27.89% | 25.03% | 0% |
| Return on invested capital | -20.26% | 8.36% | 9.37% | 0% |
| Profitability | 0% | 97% | 83% | 0% |
| Total debt ratio | 52.89% | 81.28% | 59.58% | 0% |
| Debt ratio change over time | -3.88% | -11.36% | -57.43% | 0% |
| Dept financing | 16% | 25% | 18% | 25% |
| Current Ratio | 4.74% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 2.13% | 0.12% | 0.5% | 0% |
| Liquididy | 75% | 14% | 17% | 0% |
| Short-term ratios | TSVT | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -3.32% | 4.32% | 3.49% | 0% |
| Return on sales | -369.34% | 28.32% | 23.63% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 41% | 0% |
| Total debt ratio | 55.37% | 81.66% | 60.28% | 0% |
| Debt ratio change over time | -3.47% | 0% | 0% | 0% |
| Dept financing | 17% | 25% | 43% | 0% |
| Current Ratio | 4.74% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 2.13% | 0.12% | 0.5% | 0% |
| Liquididy | 50% | 33% | 35% | 0% |
